As an acute-phase protein markedly upregulated in metabolic disorders, SAA can act on endothelial cells, vascular smooth muscle cells, and infiltrating immune cells to enhance pro-inflammatory signaling, oxidative stress, and extracellular matrix remodeling. This evidence concerns the gene SAA2 and metabolic disease.